A study of the nurse shark has revealed a type of rearranging gene that has yet to be seen in mammals; it encodes a secreted 'new antigen receptor' which, unlike shark immunoglobulin, revels in somatic hypermutation.
In function, the mammalian immune system stands out for the specificity, memory and versatility of its response to foreign bodies. These attributes stem from the concerted activity of large families of variable antigen-binding molecules. T-cell receptors (TCRs) and immunoglobulins (the antigen receptors of B cells) are the end products of an elaborate orchestration of somatic evolution in which gene segments are pasted together and modified with abandon. More restrained are the class I and II major histocompatibility complex (MHC) molecules that present antigens to TCRs; although stable entities within the individual, MHC genes 'experiment' within populations, where their products can evolve at rates deemed unacceptably high by the standards of other cellular proteins.
Most studies of the immunological specificity of the four families of antigen-binding protein represent investigations in molecular evolution: the adaptation of proteins to changing circumstance. Not surprising then is the temptation for immunologists to dwell on the origins of the system to which they have dedicated their neurons. So far, phylogenetic comparisons have failed to identify species with an obviously rudimentary immune system -for example, one having a single type of 'primordial' lymphocyte receptor, or just one class of antigen-presenting molecule [1] . Yeast, fruit flies and Sydney Brenner's worms are clearly not immunologically inclined, but it is hard to find a vertebrate that, on provocation, does not indulge in immunoglobulins, TCRs and the two classes of antigen-presenting molecules. Representatives from cartilaginous and bony fish, amphibians, reptiles, birds and mammals have replied uniformly in the affirmative; those holding out are the jawless fish -hagfish and lampreys -for which complement has been recognized [1, 2] , but as yet no glimpse of a variable antigen-binding protein is to be seen.
The usual strategy for the comparative immunologist is to seek for molecules (or functions) in 'lower' species that conform -give or take a bit -to paradigms developed from the study of mammals. Experimentally, this approach has limitations, because many experimental assays are robust only at identifying entities closely related to those already known. The inherent dangers are perhaps most keenly demonstrated by comparative studies, not of phyla but of lymphocyte lineages: witness the decade of difficulties encountered in translating the antibody paradigm into an effective strategy for the identification of the TCR, a molecule which we now know is in many ways quite like an antibody [3] .
Conceptual limitations may also intrude -for example, the assumption that the phylogenetic sweep of modern vertebrate species, from sharks to clerks, encompasses a gradual progression in immune systems, from simple, less effective concatenations of cells and molecules to those more complicated and useful. Given the comfort of such bromides, it was not difficult to believe, in the mid 1980s, with the discovery and description of the at3 and ,y TCRs [3] , that the major players of immunological specificity were defined. Nibbling at this notion, a recent report in Nature by Martin Flajnik and coworkers [4] describes a new class of rearranging gene whose product looks and smells like an antigen-binding molecule of the immune system. Ironically, this latest addition to the rearranging gene family was discovered not in a species at the pinnacle of phylogenetic progression, but in a representative of one of the most ancient forms of vertebratethe nurse shark, Ginglymostoma cirratum (Fig. 1 ).
Although immunology is renowned for its sharks, knowledge of their immune systems remains sketchy. Despite the name, nurse sharks, which can reach 4.3 meters in length, will bite when provoked [5] , perhaps contributing to the paucity of reported knowledge. These 'primitive' cartilaginous fish express IgM as their only immunoglobulin [1, 6] . By comparison to mammals, their antibody repertoire is limited, due to a lack of combinatorial association between the variable (V), diverse (D) and joining (J) gene segments. This arises from a distinct arrangement of these segments within the immunoglobulin heavy and light chain loci (Fig. 2) . From studies of the horned shark, Heterodontus francisci, Gary Litman and coworkers [7, 8] have shown these loci consist of a sequential series of clusters, each consisting of V, D, J and constant (C) segments which preferentially rearrange within the cluster. A similar arrangement is also indicated for the nurse shark. Adding to the restrictions imposed on the shark IgM response is the absence of affinity maturation through somatic hypermutation [9] [10] [11] [12] ; this is often a property of IgM in mammals, but in those species switching of the antibody isotype -for example to IgG, the major serum immunoglobulin -is associated with hypermutation [13] . As a consequence of lacking hypermutation, shark antisera tend to be low in both titre and affinity and prone to crossreactivity.
Greenberg et al. [4] picked out their prize using a strategy aimed at the identification of molecules having immunoglobulin domains similar to those found in the immunoglobulin, TCR and MHC families. A cDNA library made from nurse shark spleen mRNA was screened by the polymerase chain reaction; the 5' oligonucleotide primer corresponded to the conserved sequence motif preceding and including the first cysteine of the intradomain disulphide of immunoglobulin constant domains, and the 3' primer to an 'adapter' sequence introduced purposely into the 3' end of each cDNA during construction of the library. Products emerging from two successive rounds of such amplification were separated by gel electrophoresis, whereupon individual 'bands' were eluted and used to rescreen the cDNA library. In an earlier paper published in Proceedings of the National Academy of Science USA, Greenberg et al. [14] described how such screening with a band corresponding to 850 base-pairs in length found a cDNA clone encoding a light chain of shark IgM; in their letter to Nature [4] , they report on a cDNA of 2.4 kilobases obtained by screening with a 700 base-pair band.
Translation of the nucleotide sequence revealed this latter clone to encode a secreted protein consisting of five immunoglobulin domains (Fig. 3) . The amino-terminal domain was of the type (denoted V-SET by Williams and Barclay [15] ) found in the variable regions of immunoglobulins and TCRs, whereas the remaining four carboxyterminal domains were of the type (denoted C1-SET) found in immunoglobulins and TCR constant regions. Like good scouts, Greenberg et al. [4] already had monoclonal antibodies specific for the protein productraised against a partially purified preparation of low molecular weight shark IgM -with which they demonstrated its presence as a major serum component distinct from IgM. On denaturing gels the protein appears as a disulphide-bonded homodimer, or higher multimer, of a polypeptide of molecular weight 80-85 kilodaltons.
Greenberg et al. [4] have given their discovery the acronym NAR, which they tell us can stand for either new or nurse shark antigen receptor. Ambiguity in the 5' part of the name leaves the door open to a range of future developments: at one extreme the realization that NAR is probably a caprice of the nurse shark, and at the other the unequivocal demonstration that NAR is an unanticipated, yet extremely important, component of the immune syste/ of the laboratory mouse. Being immunology, assignment of the constant 3' part of the name -'antigen receptor' -is not based upon an actual demonstration of antigen binding or receptor function, but upon sequence comparisons suggesting that NAR genes somatically rearrange and mutate themselves in ways similar to those that distinguish genes encoding the familiar immunoglobulin and TCR antigen receptors.
Further screening of the cDNA library yielded 16 distinci NAR clones that vary primarily in the sequences of their V domains. Substitutions are clustered in three regions corresponding to the complementarity-determining regions (CDRs) that form the antigen-binding site of immunoglobulins [15] . The CDR3 of NAR contains the most substitutions and, in addition, exhibits length polymorphism. A similar pattern in immunoglobulin heavy chain genes is due to somatic rearrangement, which brings together different V, D and J gene segments. The CDR3 of immunoglobulin heavy chains is encoded by small D segments of different length and their variable junctions with V and J gene segments. That the pattern of sequence diversity found in the NAR V region results from a familiar system of gene rearrangement is supported by the structure of genomic DNA clones encoding NAR V regions isolated from shark erythrocytes, cells assumed to preserve the germ-line configuration of rearranging genes. In the genomic clones, the C-region domains are encoded by separate exons placed at some distance downstream from the cluster of gene segments encoding the V-region domain. In the three genomic clones analyzed, this cluster consists of single V and J segments separated by a region containing three D segments. Furthering the argument for NAR being a rearranging gene is the presence of promoter elements and recombination-site signals that characterize immunoglobulin and TCR genes.
Southern blots point to nurse sharks having just a few NAR genes. Indeed, the 16 cDNA sequences form two groups based upon a substitution in the first constant region domain that is linked with substitutions in the noncomplementarity-determining regions of the V domain.
This suggests that as few as two genes (with some allelic polymorphism) could account for the detected diversity. To track the diversification of a single V-region segment, Greenberg et al. [4] isolated cDNA clones corresponding to one of the germ-line V genes. Analysis of both the genomic clones and the cDNA species was performed on tissues obtained from the same nurse shark. The result to emerge from this analysis was the finding of tremendous diversity within the V region segment itself, in addition to that created by rearrangement with D and J segments. Only 2 of 30 V-region segments analyzed retained the germ-line sequence; the others had unique sequences differing by up to 6 % in their nucleotide sequence, -and 2-20 amino-acid substitutions in 102 residues. If this family of cDNAs are the product of a single V-gene segment, then only somatic mutation can explain their divergence. Again, this is no unfamiliar phenomenon [13] . On activation by antigen, immunoglobulin-but not TCRencoding genes undergo somatic mutation, leading to the selection of cells secreting higher affinity antibodies as the immune response matures. In highly immunized mice, the degree of somatic mutation can reach 5 %, a level comparable to that seen for NAR in the nurse shark.
The NAR has many of the trappings of an antigenbinding molecule, and casual comparison of the nucleotide and protein sequences suggests that natural selection in the watery world of sharks is busily at work in the diversification of one or more binding sites. In sharks, it seems, diversification by two distinct mechanismsgerm-line variability coupled with gene rearrangement, and somatic hypermutation -are the properties of distinct classes of complementary antigen-binding proteins, IgM and NAR, respectively. In developing the repertoire of mammalian IgG, these two mechanisms are conjoined. Despite the strength of the circumstantial evidence, NAR, unlike IgM and IgG, has yet to be observed directly binding antigen -a scenario that follows the illustrious precedent set a decade ago by the TCR. Flajnik and coworkers are now in the enviable position of having their work cut out -possibly for a long time. They must determine the antigen-binding properties of NAR: its specificity, valency and quaternary structure. What cells make NAR, and are they different from those that make IgM? Does NAR production respond to immunization, or is the production process more a random generator of antigen-binding molecules that just accumulate during the long lives of sharks?
And then, what of tolerance? The evidence presented by Greenberg et al. [4] points to NAR being solely a secreted product, having no alternatively spliced membranebound form that can act as a cell receptor. If that really is the case, then it is more difficult to see how interactions with antigen can select or influence the abundance and specificity of secreted NAR. Perhaps those monoclonal antibodies should be used to look for membrane-bound forms of NAR, and for NAR receptors.
If all this speculation bears fruit, NAR will be an example of a natural antigen-binding molecule made from a single polypeptide chain. This is a simpler structure than seen for any immunoglobulins or TCR, and one that can be considered (according to taste) as either ultimately primitive or supremely refined. Another example comes from camels and llamas. By an apparent splicing-out of the first constant region, these species make antigen-binding dimers of IgG heavy chains that are 'devoid of light chains' [16] . Camels are clearly in the business of improving the familiar 'two heavy and two light chain' IgG structure. For sharks the verdict is not yet in. The arrangement of gene segments in NAR is analogous to the clusters seen in the shark immunoglobulin genes, suggesting that the two gene families share a common origin. One possibility is that NAR most closely represents a common ancestor of the genes encoding the immunoglobulin and TCR families. Alternatively, NAR may represent the divergent products of a renegade cluster of gene segments that became liberated from the rigid constraints of the immunoglobulin heavy chain locus. Whatever the function or the evolutionary relationships of NAR, the dogma that sharks never dabble in hypermutation has seriously been challenged. Now Flajnik and coworkers might profitably turn their attention toward other species -even mammals and jawless fish -to see if their immunity is (or can be) boosted with NAR.
